Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Conditions:   Tuberculosis;   Pre-XDR-TB;   Extensively Drug-Resistant Tuberculosis;   Multi Drug Resistant Tuberculosis;   Rifampicin Resistant Tuberculosis Interventions:   Drug: Bedaquiline Oral Tablet;   Drug: Linezolid Oral Tablet;   Drug: Delamanid in Oral Dosage Form;   Drug: Clofazimine Oral Product;   Drug: Levofloxacin Oral Tablet;   Drug: Isoniazid Oral Product;   Drug: Ethambutol Oral Product;   Drug: Pyrazinamide Oral Pro duct Sponsors:   Wits Health Consortium (Pty) Ltd;   Regents of the University of California;   University of Cape Town;   Perinatal HIV Research Unit of the University of the Witswatersrand Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials